(Q41214653)

28 September 2017

1 reference

title

In vivo pharmacological effects of ciclosporin and some analogues (English)

1 reference

28 September 2017

1 reference

Borel JF

1

1 reference

28 September 2017

Baumann G

2

1 reference

28 September 2017

Chapman I

3

1 reference

28 September 2017

Donatsch P

4

1 reference

28 September 2017

Fahr A

5

1 reference

28 September 2017

Mueller EA

6

1 reference

28 September 2017

Vigouret JM

7

1 reference

28 September 2017

publication date

1 January 1996

1 reference

28 September 2017

published in

Advances in Pharmacology

1 reference

28 September 2017

volume

35

1 reference

28 September 2017

page(s)

115-246

1 reference

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Renal transplant function after ten years of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporins A, G, and H on normal and ichthyotic keratinocyte growth in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Suppression of the allergic contact reaction in the guinea pig by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A does not affect epidermal proliferation following standardized injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Interaction of bromocriptine and cyclosporine in insulin dependent diabetes mellitus: results from the Canadian open study.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Allograft vein patency in a canine model. Additive effects of cryopreservation and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced autoimmunity in rats carrying thymus allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The HLA class II genes and products: the HLA-D region

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Molecular mechanisms of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Differential effects of X-irradiation and cyclosporin-A administration on the thymus with respect to the generation of cyclosporin-A-induced autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Macrophages as targets for inhibition by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Enigmatic action of ciclosporine A on the naloxone-precipitated morphine withdrawal syndrome in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Loss of medullary dendritic cells in the thymus after cyclosporine and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced cell-mediated injury of the thymic medullary epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of IL-2 receptor expression in vivo: response to concanavalin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Site-specific suppression of cell-mediated immunity by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Atrial natriuretic peptide inhibits cyclosporin A-induced endothelin production and calcium accumulation in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A and Trichinella spiralis: anthelminthic effects in immunosuppressed mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The skin immune system: progress in cutaneous biology

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Evidence that rat renal allografts are rejected by cytotoxic T cells and not by nonspecific effectors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Attenuation of allergic airway inflammation in IL-4 deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine absorption following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Long-term efficacy and safety of cyclosporine in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Liver transplantation today

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cytokines in T-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Suppressor cells of popliteal lymph node origin are involved in thein vivo andin vitro control of experimental allergic encephalomyelitis effector cells in the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effe

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A: antiparasite drug, modulator of the host-parasite relationship and immunosuppressant

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Action of cyclosporin A on the tapeworms Hymenolepis microstoma, H. diminuta and Mesocestoides corti in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

In vivo activation of macrophages by prolactin from young and aging mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T cell activation in the presence of cyclosporine in three in vivo allograft models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Syngeneic graft-versus-host disease induced by cyclosporine--a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Evidence that cyclosporine treatment during pregnancy predisposes offspring to develop autoantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Requirement of nuclear prolactin for interleukin-2--stimulated proliferation of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Regulation of autoimmune disease physiological and therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of bromocryptine-induced hypoprolactinemia on xenogeneic and allogeneic skin graft survival in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporine on immunologic mechanisms in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T lymphocyte activation in acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Experimental erythrocyte autoimmunity prevented by suppressor T cells in mice treated with Cyclosporin-A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The balance between deletion and activation of CD4+8+ thymocytes is controlled by T cell receptor-antigen interactions and is affected by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Evidence that opiate addiction is in part an immune response. Destruction of the immune system by irradiation-altered opiate withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Does the immune system communicate with the central nervous system? Interferon modifies central nervous activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine alters opiate withdrawal in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effects of in vivo cyclosporin A administration on rat thymic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine and alpha-interferon do not attenuate morphine withdrawal in rats but do impair thermoregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Comparison of Effects of Transforming Growth Factor-Beta and Cyclosporin A on Antigen-Presenting Cells of Blood and Epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Airway epithelial cells and mediators of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Mucosal inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Bromocriptine and cyclosporin A combination therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Evidence of neuro-immunologic interactions: cyclosporine modifies opiate withdrawal by effects on the brain and immune components

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The brain and the immune system: an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Trough concentrations of cyclosporine in blood following administration with grapefruit juice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effects of cyclosporin A on leucocyte infiltration and procoagulant activity in the mouse delayed hypersensitivity response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Blood eosinophils and eosinophil-derived proteins in allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Rapidly proliferative arteriopathy in cyclosporin-induced permanently surviving rat cardiac allografts simulating chronic vascular rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The optimal use of cyclosporin A in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Long-term outlook for renal transplant recipients with one-year function. "Doctor, what are my chances"?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Development of tolerance to class II-mismatched renal transplants after a short course of cyclosporine therapy in miniature swine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Evidence that recipient CD8+ T cell depletion does not alter development of chronic vascular rejection in a rat heart allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Specific incorporation of cyclophilin A into HIV-1 virions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Prolonged survival of renal transplants in nonimmunized and hyperimmunized rats receiving a platelet-activating factor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Myeloid and lymphoid cell alterations in normal mice exposed to chemotherapy with doxorubicin and/or the multidrug-resistance reversing agent SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Immunophilins in protein folding and immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporin A on T cell immunity. I. Dose-dependent suppression of different murine T helper cell pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of cyclosporin A on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Peptidylproline cis/trans isomerases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin increases granulocyte/macrophage colony-stimulating factor (GM-CSF) activity and gene expression in murine keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Abnormal differentiation of thymocytes in mice treated with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of a primary immune response to T-cell dependent antigen on serotonin metabolism in frontal cortex: in vivo microdialysis study in freely moving Fischer 344 rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Control of glucan-induced systemic granulomatosis by cyclosporine A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Regulation of murine germinal centre cell proliferation in vivo: a stathmokinetic study examining the effect of differently timed doses of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Mast cells as a source of multifunctional cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Lymphokine gene expression in vivo is inhibited by cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Optimisation of immunosuppressive therapy using pharmacokinetic principles

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Immune and inflammatory mechanisms in the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T lymphocytes inhibit the vascular response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Role of lymphokine in islet allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of early administration of donor bone marrow cells on renal allograft survival in dogs treated with antilymphocyte serum and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Beneficial effect of cyclosporine pretreatment in canine liver ischemia. Enzymatic and electronmicroscopic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Chronic allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits the interleukin 2 receptor alpha chain gene transcription but not its cell surface expression: the alpha chain stability can explain this discrepancy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Suppression of DTH mediated by cloned helper T cells with ciclosporin and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

In vivo effects of cyclosporin A: abrogation of the induction of experimental allergic orchitis and sparing of the generation of suppressor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Molecular and biological actions of cyclosporin A and FK506 on T cell development and function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Causes of late renal allograft failure in the ciclosporin era

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporin on hair-existing area of nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Kinetics of thymocyte subset development and selection revealed by cyclosporin A treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A renders target cells resistant to immune cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporin A on suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Risk factors predicting chronic rejection of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Soluble antigen and cyclosporine-induced specific unresponsiveness in rats. Frequency of alloantigen-specific T cytotoxic cells in normal, sensitized, and unresponsive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of allograft tolerance with neonatal skin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporine A on T cell development and clonal deletion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cytotoxic cell proteinase gene expression and cytolytic activity by anti-CD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin A but is not dependent on interleukin-2 synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T cell tolerance by clonal elimination in the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine in dermatology: pharmacology and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16-213) enhance in vivo cytostatic activity and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Influence of ciclosporin on epidermal proliferation after mechanical skin irritation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Direct effect of cyclosporin A on CD8+ T lymphocytes in a primary mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

HIV infection: facts and hypotheses.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Does cyclosporine act in vivo as it does in vitro?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-sensitive and cyclosporine-insensitive modes of B cell stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Blocking of acquisition and presentation of antigen by dendritic cells with cyclosporine. Studies with fluorescein isothiocyanate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Controlled cyclosporine conversion at three months after renal transplantation. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

An in vitro model for cyclosporin A-induced interference of intrathymic clonal elimination

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The viable motheaten (mev) mouse--a new model for arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporin A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The importance of lymphocyte migration patterns in experimental organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Sparing of suppressor cells: a critical action of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Beneficial effects of cyclosporine on postischemic liver injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Anti-idiotypic T cells suppress rejection of renal allografts in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of cyclosporin on murine autoreactive delayed type hypersensitivity induced with syngeneic lymphoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Therapeutic monitoring of cyclosporin ? an update

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The role of the CD28 receptor during T cell responses to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

FK506 and cyclosporin, molecular probes for studying intracellular signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Site-specific immune suppression with topical cyclosporine. Synergism with combined topical corticosteroid added during the maintenance phase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Morphine receptors in immunocytes and neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporine on the antigen-presenting function of human and murine accessory cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Short-term effects of cyclosporine on secretagogue-induced insulin release by isolated islets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibition of the accumulation, in rat kidney allografts, of specific--but not nonspecific--cytotoxic cells by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Properties of suppressor cells induced to acetylcholine receptor using cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cryopreserved venous allografts: effects of immunosuppression and antiplatelet therapy on patency and function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Progression of kidney disease in chronic renal transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Areas for further experimentation to elucidate the immunosuppressive activity of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The impact of azathioprine and cyclosporine on long-term function in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Anti-CD4 monoclonal antibody therapy in severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A in asthma therapy: a pharmacological rationale

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Interleukin 2/interleukin 4-independent T helper cell generation during anin vitro antigenic stimulation of mouse spleen cells in the presence of cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T suppressor cells induced by transfusions and cyclosporine. Studies in the murine cardiac allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Safety and steady-state pharmacokinetics of a new oral formulation of cyclosporin A in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Lack of influence of cyclosporine on antigen presentation to lysozyme-specific T cell hybridomas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The larvicidal activity of cyclosporin A against Schistosoma mansoni in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Schistosoma mansoni: morphology and ultrastructure of adult worms recovered from cyclosporin A-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Toxicity of cyclosporin A (CsA) against developmental stages of Schistosoma mansoni in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Stage-selective inhibition of rodent malaria by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine. Radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Experimental pulmonary eosinophilia in mice by Ascaris suum extract

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effect of cyclosporin A on endothelin synthesis by cultured human renal cortical epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Influence of cyclosporine on CTL behavior in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

In vivo mechanisms of alloreactivity--IV. Cyclosporine differentially impairs accumulation of donor-reactive CTL but not donor-reactive alloantibody in murine sponge matrix allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Direct and indirect modes of action of cyclosporine on cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporin A on resident and passenger immune cells of normal human skin and UV-induced erythema reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Initiation of cardiac allograft rejection New developments in cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Factors secreted by untreated psoriatic monocytes enhance neutrophil functions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

SDZ PSC 833 and SDZ 280-446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T-cell maturation and clonal deletion in cyclosporine-induced autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine, tolerance, and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Molecular characteristics of cyclophilin-cyclosporine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A exerts a cytostatic effect in vivo on human and murine epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Weaning of immunosuppression in long-term liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of cyclosporin A on disease progression in proliferative immune complex glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits endothelium-dependent, prostanoid-induced relaxation in human subcutaneous resistance vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Analysis of the kinetics of antiviral memory T help in vivo: characterization of short-lived cross-reactive T help

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Production of indefinite renal allograft survival in the rat by pretreatment with viable and nonviable hepatocytes or liver membrane extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The failure of skin grafting to break tolerance to class I-disparate renal allografts in miniature swine despite inducing marked antidonor cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Use of cyclosporine in chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A: Effects on the mouse thymus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of apoptosis in mouse thymocytes by cyclosporin A: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of apoptosis in mouse thymocytes by cyclosporin A: in vivo study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Causes and mechanism of autoimmune disease: cyclosporin A as a probe for the investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Vascularized osteochondral allografts in an immunosuppressed rat model: graft modulation and host immune tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

In vivo effects of cyclosporine on influenza A virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cardiac transplant graft arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Monoclonal anti-tumor necrosis factor-alpha antibody treatment of rat cardiac allografts: synergism with low-dose cyclosporine and immunohistological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Chronic renal transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine increases muscular force generation in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Time-dependent inhibition of growth of human keratinocytes and fibroblasts by cyclosporin A: effect on keratinocytes at therapeutic blood levels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A does not affect the in vitro induction of antigen-specific delayed-type hypersensitivity-mediating T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibition of T cell development in thymic organ culture: implications for the mechanism of action of cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of antigen-specific tolerance by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T line cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin for steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Endothelin-1 release from the mesenteric arteries of cyclosporine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Clinical kidney transplants, 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Renal transplantation in older people

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced hypertension after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Functional association of cyclophilin A with HIV-1 virions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effects of cyclosporin A on non-T cell components of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Immunosuppressive drugs and the induction of transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

[Melle4]Cyclosporin, a Novel Natural Cyclosporin with anti-HIV Activity: Structural Elucidation, Biosynthesis and Biological Properties

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

New cyclopeptides from Trichoderma polysporum (Link ex Pers.) Rifai: cyclosporins B, D and E (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A: a tool for dissecting the mechanisms of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin absorption from microemulsion formulation in liver transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine in rheumatoid arthritis: documented efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Self-reactive T cells are present in the peripheral lymphoid tissues of cyclosporin A-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Current understanding of the role of the eosinophil granulocyte in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Exercise-induced asthma and the generation of neutrophil chemotactic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Thymocytes bearing high-density T cell receptor and CD2 are selectively eliminated in cyclosporine-induced thymic atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Self-nonself discrimination by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The role of the eosinophil in the pathogenesis of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A: drug treatment in vivo affects the kinetics of [14C]glucose transport in Hymenolepis microstoma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Action of cyclosporin A on the tapeworm Hymenolepis diminuta in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Effects of cyclosporin A on the morphology and tegumentary ultrastructure of Hymenolepis microstoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine inhibits the development of medial thickening after experimental arterial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The induction of tolerance by cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Suppressor cell regulation of encephalitogenic T cell lines: Generation of suppressor macrophages with cyclosporin A and myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The role of genetically-determined primary alterations of the target organ in the development of spontaneous autoimmune thyroiditis in obese strain (OS) chickens

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Suppression of B cell activation by cyclosporin A, FK506 and rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of hypoprolactinemia alone and in combination with cyclosporine on allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporin A inhibits keratinocyte cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The mechanisms of action of cyclosporin A in the treatment of psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cell-Mediated Immune Responses in Renal Transplant Recipients treated with Cyclosporin and Prednisolone with or without Azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Hypertrichosis in patients receiving cyclosporine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Induction of contraction in isolated rat aorta by cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Mechanism of suppression of cloned human suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

CsA, FK506, corticosteroids and rapamycin inhibit TNF alpha production by cultured PTEC.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Use of mixed islets from two strains as the donor for single transplantation. Induction of donor-specific unresponsiveness to each strain by cyclosporine and intraportal grafting

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Pharmacokinetic drug interactions with cyclosporin (Part I).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

The effect of cyclosporin A on Angiostrongylus cantonensis infection and eosinophilia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

Demonstration of large-scale migration of cortical thymocytes to peripheral lymphoid tissues in cyclosporin A-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960276-8

7 January 2021

10.1016/S1054-3589(08)60276-8

Identifiers

DOI

0 references

1 reference